Winner Medical Co., Ltd. (300888.SZ)
CNY 40.96
(0.1%)
CNY 40.96
(0.1%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 170 Million CNY | -47.93% |
| 2022 | 326.45 Million CNY | -14.5% |
| 2021 | 381.8 Million CNY | 4.94% |
| 2020 | 363.82 Million CNY | 171.09% |
| 2019 | 134.21 Million CNY | 2584.21% |
| 2018 | 5 Million CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 304.17 Million CNY | -100.0% |
| 2024 Q3 | 70.72 Million CNY | 0.0% |
| 2024 Q1 | 170 Million CNY | 0.0% |
| 2023 Q3 | 449.55 Million CNY | -7.11% |
| 2023 FY | 170 Million CNY | -47.93% |
| 2023 Q4 | 170 Million CNY | -62.19% |
| 2023 Q1 | 519.41 Million CNY | 59.1% |
| 2023 Q2 | 483.94 Million CNY | -6.83% |
| 2022 Q3 | 337.62 Million CNY | -2.0% |
| 2022 Q1 | 326.33 Million CNY | -14.53% |
| 2022 FY | 326.45 Million CNY | -14.5% |
| 2022 Q4 | 326.45 Million CNY | -3.31% |
| 2022 Q2 | 344.52 Million CNY | 5.57% |
| 2021 Q4 | 381.8 Million CNY | -36.46% |
| 2021 Q2 | 616.98 Million CNY | 6.03% |
| 2021 Q1 | 581.87 Million CNY | 59.93% |
| 2021 FY | 381.8 Million CNY | 4.94% |
| 2021 Q3 | 600.87 Million CNY | -2.61% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 FY | 363.82 Million CNY | 171.09% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q4 | 363.82 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q1 | 124.77 Million CNY | 0.0% |
| 2019 FY | 134.21 Million CNY | 2584.21% |
| 2019 Q4 | 134.21 Million CNY | 0.0% |
| 2019 Q2 | 124.77 Million CNY | 0.0% |
| 2018 FY | 5 Million CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |